IP Verse

Acorda Therapeutics competitive analysis

Latest publications and patents of Acorda Therapeutics New

Explore the latest publications and patents granted to Acorda Therapeutics, showcasing their recent innovations and technological advancements.

Last updated on: Sep 23, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Acorda Therapeutics

EP2377536
Aug 17, 2022Methods Of Using Sustained Release Aminopyridine CompositionsPatent Maintained As Amended

Latest patents of Acorda Therapeutics opposed by its competitors

Explore Acorda Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 25, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP2377536
Aug 17, 2022Methods Of Using Sustained Release Aminopyridine Compositions3

Latest PTAB cases involving Acorda Therapeutics

Discover the latest PTAB cases involving Acorda Therapeutics, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 29, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Acorda Therapeutics

IPR2015-01858Sep 3, 2015COALITION FOR AFFORDABLE DRUGS ADROCAACORDA THERAPEUTICSFinal Written Decision
IPR2015-01857Sep 3, 2015COALITION FOR AFFORDABLE DRUGS ADROCAACORDA THERAPEUTICSFinal Written Decision
IPR2015-01853Sep 2, 2015COALITION FOR AFFORDABLE DRUGS ADROCAACORDA THERAPEUTICSFinal Written Decision
IPR2015-01850Sep 2, 2015COALITION FOR AFFORDABLE DRUGS ADROCAACORDA THERAPEUTICSFinal Written Decision
IPR2015-00817Feb 27, 2015COALITION FOR AFFORDABLE DRUGS ADROCAACORDA THERAPEUTICSInstitution Denied
IPR2015-00720Feb 10, 2015COALITION FOR AFFORDABLE DRUGS ADROCAACORDA THERAPEUTICSInstitution Denied

Peer Comparison New

IP litigation analysis comparing Acorda Therapeutics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
ACORDA THERAPEUTICS - 3 - 6Non-Active
ACTAVIS GROUP PTC EHF1 - - - Highly Aggressive
COALITION FOR AFFORDABLE DRUGS ADROCA - - 6 - Highly Aggressive
NEURAXPHARM ARZNEIMITTEL4 - - - Highly Aggressive